Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | FNTA | P49354 | 1/20 | 0.42 |
| ▸ | FNTB | P49356 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | POLA1 | P09884 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18992879 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TSHRLMNAKMT2ADGKA | |
| SCHEMBL8467495 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TSHRLMNAKMT2ADGKA | |
| SCHEMBL7874317 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TSHRLMNAKMT2ADGKA | |
| SCHEMBL7235711 | 0.98 | TSHR (0.67) | ALDH1A1TSHRLMNAKMT2ADGKA | |
| SCHEMBL18266869 | 0.92 | ALDH1A1 (0.55) | ALDH1A1TSHRLMNADGKA | |
| SCHEMBL907647 | 0.90 | — | — | |
| SCHEMBL3502791 | 0.87 | TSHR (0.82) | ALDH1A1TSHRLMNAKMT2ADGKA | |
| SCHEMBL494114 | 0.87 | TSHR (0.82) | ALDH1A1TSHRLMNAKMT2ADGKA | |
| SCHEMBL3503395 | 0.87 | TSHR (0.82) | ALDH1A1TSHRLMNAKMT2ADGKA | |
| SCHEMBL3503548 | 0.87 | TSHR (0.82) | ALDH1A1TSHRLMNAKMT2ADGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212136-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT | FUJIFILM CORPORATION (JP) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212136-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT | TERB1, RER1, LARP1 | ALDH1A1 228/4885TSHR 3138/4885LMNA 1226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.